Comments
Description
Transcript
PDFファイル
**2015 11 *2014 ) ) 10 (07) ) 21900BZY00011000 70488000 AAA- 2 0 1 5 0 2 - 1 1 ® 9) 1) 10) 11) 2) 1) 2) 19-32mm 15mm 60° 1) 8-25mm ® 10cm ® 2) 3) ] 3) 4) (DSA) 5) 6) 4) 7) 5) 6) 7) 8) 21 1/8 • ] AAA ( • *• 16 18 20mm: *• 23mm: *• 27mm: 10cm 1) (PTFE) FEP 3cm 4cm 5cm 6cm ( 10cm ) PTFE/FEP PTFE/FEP PTFE/FEP *( ) ® X X 3 1 X 3cm X 1 3.3cm 4.5cm X X 7cm X X 1 1 X X 3 X ** X /PTFE/FEP X PTFE X X 12 14.5mm 3 ] 23 26 28.5mm * 31 35mm† ) PTFE/FEP *† • • • • X 1) *2) X 19-32mm 15mm 3) *4) 60° 8-25mm 10mm 12 14.5mm ** • X X 16 18 20 23 27mm 145cm ** ** 2/8 0.035 (0.89mm) (super-stiff) ** * 3. ) 14mm * (mm) (mm) †1 19-21 23 22-23 26 24-26 28.5 27-29 32 *30-32 *36 † 1 *†2 (Fr) †2 (cm) 16†3, 18 3.3 16†3, 18 (28.5mm 18Fr) *17†3 4.5 18Fr), 20 *18 10-21% 40cm ] *†3 2mm (10-21% 1mm PLA ** 4. ) 7-25% (mm) ** 1. 8-9 10 10-11 12-13.5 12†5 14.5†5 ) † (mm) (mm) †1 19-21 (mm) 23 22-23 26 24-26 28.5 (mm) †1 10-11 12-13.5 12 14.5 10-11 12 12-13.5 14.5 10-11 12-13.5 12 14.5 †2 (Fr)†3 (cm) † † 31 12-13.5 14.5 13, 15, 17 18†4, 20 *35†4 *12-13.5 *14.5 *14, 16, 18 *18 1 2 *†3 10-21% 12mm 7 12 (mm) (mm)†4 14 12 14 10 7-25% 4cm 40cm 40mm 12 14.5mm 1. 7-25% 14mm **2. 40cm **†4 (Fr)†3 18 27-29 † (cm) †2 3cm *4 **†5 16 , 18 12, 14, 16, 18 *30-32 † 1 2 3 † †4 (mm) †1 RLT 3mm 3. DSA CT ** 2. (mm) 10 - 11 ) †1 (mm)†2 12 (cm) †3 †4 10, 12, 14 12 -13.5 14.5 13.5 -14.5 14.5 -16.5 16 18 16.5 -18.5 20 18.5 -21.5 *23 4. 5. (mm) (Fr)†5 (mm)†6 12 1. 14 12 14 9.5, 11.5, 13.5 *10, 12, 14 16 18 †8 *12 , 18 *2. 20 3. 14†7 *14 15mm 19-32mm *24 60° *15 21.5 -25 *27 4. *28 *10, 12, 14 16Fr) **†1 † 2 *†3 7-25% 23 26 28.5mm 35mm † 4 *†5 5cm( 4cm( 31mm 6cm( 2mm 3cm 40cm *5. † 6 40mm * 7 16 18 20 23 27mm † *†8 25% 30mm 10mm 25mm 16mm 10mm PLC 6. 7. 8. 3/8 9. 1. DSA 10. 2. 11. 3. 0.035 mm 0.89 super-stiff 4. 5. 12. 6. *13. 7. 14. 1. 2. 1. 3. 2. 0.035 super-stiff 4. **3. 5. 12 14.5mm 4. 1. 5. 2. 0.035 mm 0.89 super-stiff **6. *3. 12 14.5mm **7. 3cm 4. *8. **9. **10. 5. **11. 6. 60-70 **12. mmHg 7. **13. **8. 4/8 14mm 0.89 mm **14. 3cm 4cm 16 18 20mm 6cm 27mm 10cm **15. 5cm 23mm 1. 2. 0.035 0.89mm 7B super-stiff 18 20 23 27mm 3cm *3. *4. 4. **5. **6. 3.3cm 4.5cm 1.6cm 2.2cm **7. **8. 5. 60 70 mmHg **9. **6. 7. 8. 9. 10. * 16, 18, 20, 23, 27mm ** ** 1. 3cm 2. ** 3cm 18, 20, 23, 27mm 3. 3cm **1 **1. 12 14.5mm 3cm 3.3cm 3cm *2 1.6cm 4.5cm 2.2cm 3.3cm 1.6cm 4.5cm 3cm 16 18 20 23 27mm 2.2cm 3cm 7cm 4cm 7A 7B 7C 3cm 3cm 3cm 2. 5/8 3. CT Smart-Prep†, Care Delay 1cm ** DFOV CT ** 32cm MRI/MRA (mm/rot) CT interval)(mm) KV/mA † MRI/MRA CT CT CT Smart-Prep 32cm 0.8 0.8 3.0mm 3.0mm HS HS 15 15 2.0 2.0 120/300 120/300 3.0mm Soft 3.0mm Soft ROI Loc: 1cm Sup. delay 6sec. ISD 3sec. MA 40 3sec. Enhance thres: 100HU Supine AP Lateral 30°LPO 30° 30°RPO 30° CT CT CO2 MRI/MRA 5. 2-4 CT†1 †2 MRI MR †3 ***- 12 † ** 1 CT † 2 † 3 1 3.0 3000 /cm Specific absorption rate SAR 2.0W/kg 15 MRI ** 10-20cm 1.5 /64MHz (Magnetom, Siemens Medical Solutions,Malvern, PA. Software Numeris/4, Version Syngo MR 2002B DHHS Active-shielded,horizontal field scanner /128MHz (Excite, HDx, Software 14X.M5, General Electric Healthcare, Milwaukee, WI) MR 15 MRI 1cm Supine 7. MRI AP AP SAR SAR2.0W/kg SAR4.0W/kg **CT 3mm 3mm MR 14’’× 17’’ 20:1 ** CT ** CT ** ** CT CT 10mm MR MRI MRI 6. mL mL/sec Type Type 150 5mm 2.5 6/8 1.5 2.9W/kg 2.9W/kg 2.1W/kg 2.7W/kg 2.2 2.7 1.5 1.9 3.0 3.7 ** 16Fr 17Fr 18Fr 12Fr 14Fr 20Fr 15mm 32mm 60° 30mm 10mm 360° ** 16, 18, 20, 23, 27mm 3cm 18, 20, 23, 27mm 27mm 10cm 3cm 31 35mm 32, 36mm 15mm 22mm 15mm 7/8 25mm 9. 1 6 12 24 36 48 99 96 87 81 70 58 46 99 ‡ 68 (68.7%) 45 (45.5%) 12 (12.1%) 16 (16.2%) 3 (3.0%) 4 (4.0%) 17 (17.2%) 7 (7.1%) 3 (3.0%) 1 (1.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (1.0%) 15 (15.6%) 0 (0.0%) 3 (3.1%) 7 (7.3%) 0 (0.0%) 3 (3.1%) 2 (2.1%) 1 (1.0%) 3 (3.1%) 0 (0.0%) 0 (0.0%) 1 (1.0%) 0 (0.0%) 2 (2.1%) 10 (11.5%) 0 (0.0%) 1 (1.1%) 7 (8.0%) 1 (1.1%) 0 (0.0%) 1 (1.1%) 3 (3.4%) 2 (2.3%) 2 (2.3%) 0 (0.0%) 2 (2.3%) 0 (0.0%) 2 (2.3%) 11 (13.6%) 0 (0.0%) 2 (2.5%) 6 (7.4%) 0 (0.0%) 1 (1.2%) 1 (1.2%) 1 (1.2%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 2 (2.5%) 12 (17.1%) 0 (0.0%) 1 (1.4%) 6 (8.6%) 1 (1.4%) 2 (2.9%) 2 (2.9%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 3 (4.3%) 0 (0.0%) 2 (2.9%) 13 (22.4%) 1 (1.7%) 4 (6.9%) 6 (10.3%) 3 (5.2%) 1 (1.7%) 1 (1.7%) 0 (0.0%) 2 (3.4%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (1.7%) 3 (6.5%) 0 (0.0%) 0 (0.0%) 1 (2.2%) 0 (0.0%) 0 (0.0%) 1 (2.2%) 1 (2.2%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 80 (80.8%) 45 (45.5%) 19 (19.2%) 36 (36.4%) 7 (7.1%) 10 (10.1%) 22 (22.2%) 12 (12.1%) 9 (9.1%) 3 (3.0%) 0 (0.0%) 6 (6.1%) 0 (0.0%) 9 (9.1%) 547-911 0-60 912-1275 36 48 61-242 12 1276-1640 98-03 ® 19 235 99 EBE 32mm 03-02 EBE 98-03 Continued Access 60 † 243-546 24 60 1641-2006 98-03 31mm 03-02 2008 35 49 99-04 16 193 Continued Access EBE 88 EBE EBE(98-03 99-04) 99 1. (5mm 98-03 99-04 EBE99-04 8. † ‡ EBE98-03 98-03 2. Jon S. Matsumura et al. A multicenter controlled clinical trial of open EBE98-03 EBE99-04 1 565 105 (18.6%) 27 (4.8%) 13 (2.3%) 22 (3.9%) 9 (1.6%) 22 (3.9%) 12 (2.1%) 16 (2.8%) 7 (1.2%) 6 (1.1%) 1 (0.2%) 3 (0.5%) 0 (0.0%) 8 (1.4%) 6 553 72 (13.0%) 2 (0.4%) 13 (2.4%) 21 (3.8%) 6 (1.1%) 9 (1.6%) 5 (0.9%) 10 (1.8%) 5 (0.9%) 5 (0.9%) 2 (0.4%) 8 (1.4%) 0 (0.0%) 12 (2.2%) 12 533 91 (17.1%) 1 (0.2%) 17 (3.2%) 24 (4.5%) 5 (0.9%) 3 (0.6%) 10 (1.9%) 9 (1.7%) 12 (2.3%) 0 (0.0%) 0 (0.0%) 16 (3.0%) 0 (0.0%) 26 (4.9%) 24 483 81 (16.8%) 3 (0.6%) 10 (2.1%) 23 (4.8%) 6 (1.2%) 4 (0.8%) 10 (2.1%) 8 (1.7%) 9 (1.9%) 1 (0.2%) 2 (0.4%) 10 (2.1%) 0 (0.0%) 19 (3.9%) 36 427 64 (15.0%) 1 (0.2%) 24 (5.6%) 23 (5.4%) 6 (1.4%) 1 (0.2%) 4 (0.9%) 5 (1.2%) 8 (1.9%) 0 (0.0%) 0 (0.0%) 11 (2.6%) 0 (0.0%) 8 (1.9%) 48 361 53 (14.7%) 5 (1.4%) 10 (2.8%) 21 (5.8%) 1 (0.3%) 1 (0.3%) 2 (0.6%) 2 (0.6%) 3 (0.8%) 3 (0.8%) 2 (0.6%) 14 (3.9%) 1 (0.3%) 11 (3.0%) 60 291 22 (7.6%) 0 (0.0%) 7 (2.4%) 10 (3.4%) 3 (1.0%) 0 (0.0%) 2 (0.7%) 2 (0.7%) 0 (0.0%) 1 (0.3%) 0 (0.0%) 1 (0.3%) 0 (0.0%) 2 (0.7%) versus endovascular treatment of abdominal aortic aneurysm. J Vasc 565 326 (57.7%) 38 (6.7%) 81 (14.3%) 124 (21.9%) 30 (5.3%) 37 (6.5%) 43 (7.6%) 44 (7.8%) 38 (6.7%) 16 (2.8%) 7 (1.2%) 61 (10.8%) 1 (0.2%) 77 (13.6%) Surg, 37:262-271, 2003. TEL 03-6746-2560 W. L. Gore & Associates, Inc. U. S. A. ® 8/8 ® W. L. Gore & Associates